Key considerations for cytokine supplier selection for cell therapies

Cell & Gene Therapy Insights 2022; 8(5), 621;

DOI: 10.18609/cgti.2022.097

Published: 1 July 2022
Timothy Manning

Key considerations for cytokine supplier selection for immune cell therapies

  • Partnership: Find a supplier to help navigate the most important regulatory and manufacturing hurdles.
  • Safety: Patient safety is paramount. Learn the important questions to ask and what should you expect from your supplier.
  • Consistency: What to look for to ensure your reagents work the same every time.
  • Supply Chain: Questions to ask and techniques to use to ensure reagents are available whenever you need them.

Tim Manning is the Senior Product Manager of the Protein Business Unit at Bio-Techne with almost 20 years’ experience in the Biotech industry. For the last seven years he has focused on GMP cytokines and growth factors designed for use in clinical manufacturing. Tim received his PhD at the University of Alabama at Birmingham and was a Post-Doctoral Fellow at the University of California San Diego.